KMT2A and cancer: The herein identified roles of PRC2 and MLL/COMPASS in repressing DNA methylation deposition may represent key mechanisms in preventing the aberrant DNA hypermethylation events that typify human cancer given that PRC2- and MLL/COMPASS-protected loci are frequently hypermethylated in tumor cells.